(EXH5) iShares STOXX Europe 600 - Ratings and Ratios
Insurance, Banks, Asset Management, Reinsurance, Financial Services
Dividends
| Dividend Yield | 2.96% |
| Yield on Cost 5y | 6.81% |
| Yield CAGR 5y | 19.75% |
| Payout Consistency | 90.1% |
| Payout Ratio | - |
| Risk via 5d forecast | |
|---|---|
| Volatility | 11.8% |
| Value at Risk 5%th | 20.4% |
| Relative Tail Risk | 5.33% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.33 |
| Alpha | 24.74 |
| CAGR/Max DD | 1.62 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.413 |
| Beta | 0.028 |
| Beta Downside | 0.187 |
| Drawdowns 3y | |
|---|---|
| Max DD | 12.31% |
| Mean DD | 2.03% |
| Median DD | 1.65% |
Description: EXH5 iShares STOXX Europe 600 October 27, 2025
The iShares STOXX Europe 600 Insurance UCITS ETF (ticker EXH5) tracks the Morningstar Global Financial Services Non-Real-Estate (NR) Index in USD and is domiciled in Germany. It is classified as a sector-equity ETF focused on financial services, specifically European insurers.
Key metrics (as of Q3 2024) include an expense ratio of 0.15 % and assets under management of roughly €2.8 bn, making it one of the larger pure-play insurance ETFs in Europe. The fund’s top holdings are typically large-cap insurers such as Allianz, AXA, and Generali, which together account for over 45 % of net assets.
Insurance performance is highly sensitive to interest-rate environments because bond yields affect insurers’ investment income. With the European Central Bank’s policy rate currently around 4 %, the sector is benefiting from higher net-interest margins, but any rapid rate cuts could compress earnings. Additionally, underwriting results are driven by macro-level factors like GDP growth and inflation-adjusted premiums; the Eurozone’s Q2 2024 GDP growth of 0.6 % YoY and CPI at 3.2 % suggest modest premium growth but heightened claims pressure from climate-related events.
If you want a more granular, scenario-based assessment of EXH5’s risk-adjusted returns, the ValueRay platform offers tools that can help you model outcomes under different economic assumptions.
What is the price of EXH5 shares?
Over the past week, the price has changed by +2.22%, over one month by +5.95%, over three months by +6.85% and over the past year by +29.35%.
Is EXH5 a buy, sell or hold?
What are the forecasts/targets for the EXH5 price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 62.6 | 23.5% |
EXH5 Fundamental Data Overview December 21, 2025
Market Cap EUR = 483.4m (483.4m EUR * 1.0 EUR.EUR)
Beta = 0.7
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 483.4m EUR (483.4m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 483.4m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 483.4m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.12% (E(483.4m)/V(483.4m) * Re(6.12%) + (debt-free company))
Discount Rate = 6.12% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)